Radiosensitivity molecular signature can lead to better radiation therapy decisions f

[News]

Researchers at Moffitt Cancer Center, working with colleagues in Sweden, the Netherlands and Puerto Rico, have validated a radiosensitivity molecular signature that can lead to better radiation therapy decisions for treating patients with breast cancer.

More... (http://www.news-medical.net/news/20120816/Radiosensitivity-molecular-signature-can-lead-to-better-radiation-therapy-decisions-for-breast-cancer.aspx)